These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 38706224)

  • 1. Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis.
    Lu Y; Cui A; Zhang X
    Gut Microbes; 2024; 16(1):2348441. PubMed ID: 38706224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites.
    Yang J; Wei H; Zhou Y; Szeto CH; Li C; Lin Y; Coker OO; Lau HCH; Chan AWH; Sung JJY; Yu J
    Gastroenterology; 2022 Jan; 162(1):135-149.e2. PubMed ID: 34461052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portulaca oleracea extract reduces gut microbiota imbalance and inhibits colorectal cancer progression via inactivation of the Wnt/β-catenin signaling pathway.
    Yi S; Jin X; Liu B; Wu P; Xiao W; Chen W
    Phytomedicine; 2022 Oct; 105():154279. PubMed ID: 35963192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
    Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling.
    Zhang W; Qin X; Zhang K; Ma J; Li M; Jin G; Liu X; Wang S; Wang B; Wu J; Liu T; Zhong W; Cao H
    Cell Oncol (Dordr); 2024 Aug; 47(4):1183-1199. PubMed ID: 38315283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YYFZBJS ameliorates colorectal cancer progression in Apc
    Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
    Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.
    Sun T; Liu S; Zhou Y; Yao Z; Zhang D; Cao S; Wei Z; Tan B; Li Y; Lian Z; Wang S
    Oncotarget; 2017 Jan; 8(1):444-457. PubMed ID: 27880935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synbindin deficiency inhibits colon carcinogenesis by attenuating Wnt cascade and balancing gut microbiome.
    Ai L; Ren Y; Li Y; Chen H; Qian Y; Lu S; Xu A; Ren L; Zhao S; Chen Z; Chen YX; Xu J; Fang JY
    Int J Cancer; 2019 Jul; 145(1):206-220. PubMed ID: 30561033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between WNT/PI3K-mTOR axis and the microbiota in APC-driven colorectal carcinogenesis: data from a pilot study and possible implications for CRC prevention.
    Di Paola FJ; Alquati C; Conti G; Calafato G; Turroni S; D'Amico F; Ceccarelli C; Buttitta F; Bernardi A; Cuicchi D; Poggioli G; Turchetti D; Ferrari S; Cannizzaro R; Realdon S; Brigidi P; Ricciardiello L
    J Transl Med; 2024 Jul; 22(1):631. PubMed ID: 38970018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the NF-κB/HIF-1α signaling pathway in colorectal cancer by tyrosol: a gut microbiota-derived metabolite.
    Guo J; Meng F; Hu R; Chen L; Chang J; Zhao K; Ren H; Liu Z; Hu P; Wang G; Tai J
    J Immunother Cancer; 2024 Sep; 12(9):. PubMed ID: 39343509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intermittent hypoxia and fecal microbiota of OSAS on genes associated with colorectal cancer.
    Gao J; Cao H; Zhang Q; Wang B
    Sleep Breath; 2021 Jun; 25(2):1075-1087. PubMed ID: 33029691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional medicine Xianglian pill suppresses high-fat diet-related colorectal cancer via inactivating TLR4/MyD88 by remodeling gut microbiota composition and bile acid metabolism.
    Ye C; Wu C; Li Y; Chen C; Li X; Zhang J; Xu Z; Chen H; Guo Y
    J Ethnopharmacol; 2024 Oct; 333():118411. PubMed ID: 38824980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
    Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q
    BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis.
    Cao H; Xu M; Dong W; Deng B; Wang S; Zhang Y; Wang S; Luo S; Wang W; Qi Y; Gao J; Cao X; Yan F; Wang B
    Int J Cancer; 2017 Jun; 140(11):2545-2556. PubMed ID: 28187526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice.
    Kang X; Ng SK; Liu C; Lin Y; Zhou Y; Kwong TNY; Ni Y; Lam TYT; Wu WKK; Wei H; Sung JJY; Yu J; Wong SH
    EBioMedicine; 2023 Jul; 93():104670. PubMed ID: 37343363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Interaction Between Host and the Gut Microbiota During High-Fat Diet-Induced Colorectal Cancer.
    Lee C; Lee S; Yoo W
    J Microbiol; 2024 Mar; 62(3):153-165. PubMed ID: 38625645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.
    Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J
    Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered intestinal microbiota associated with colorectal cancer.
    Zhang H; Chang Y; Zheng Q; Zhang R; Hu C; Jia W
    Front Med; 2019 Aug; 13(4):461-470. PubMed ID: 31250341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study.
    Zhang Y; Yu X; Yu E; Wang N; Cai Q; Shuai Q; Yan F; Jiang L; Wang H; Liu J; Chen Y; Li Z; Jiang Q
    BMC Microbiol; 2018 Aug; 18(1):92. PubMed ID: 30157754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.